TRex Bio, Inc. · NASDAQ:TRXB
Svlsf VI, LLC bought 92,857 TRex Bio, Inc. shares (Form 4)
Traded Oct 8 to Oct 13, 2026 · Filed Oct 13, 2026
From Oct 8 to Oct 13, 2026, Svlsf VI, LLC (10% owner) bought 92,857 TRex Bio, Inc. shares at US$14.00 for US$1.3M, leaving 669,939 shares. Filed Oct 13, 2026 (Form 4).
- Bought
- 92,857 shares
- Price
- US$14.00
- Value
- US$1.3M
- Holding after
- 669,939 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 8, 2026 | Common Stock | Buy | 89,783 | US$14.00 | 214,869 | Indirect |
| Oct 8, 2026 | Common Stock | Buy | 3,074 | US$14.00 | 7,356 | Indirect |
| Oct 13, 2026 | Common Stock | Conversion | 1,574,074 | 1,788,943 | Indirect | |
| Oct 13, 2026 | Common Stock | Conversion | 475,411 | 2,264,354 | Indirect | |
| Oct 13, 2026 | Common Stock | Conversion | 53,892 | 61,248 | Indirect | |
| Oct 13, 2026 | Common Stock | Conversion | 16,277 | 77,525 | Indirect | |
| Oct 13, 2026 | Common Stock | Conversion | 669,939 | 669,939 | Indirect |
Source
Related
- TRex Bio, Inc.
- Svlsf VI, LLC
- TRex Bio, Inc. shareholders
- Schedule 13D · SV Biotech Crossover Opportunities Fund LP · Oct 16, 2026
- Schedule 13D · ELI LILLY & Co · Oct 16, 2026
- Schedule 13G · Pfizer Inc · Oct 16, 2026
- Form 4 · Alexandria Venture Investments, LLC · Oct 15, 2026
- Schedule 13G · Johnson & Johnson Innovation - JJDC, Inc. · Oct 15, 2026